The information on this website is not intended for diagnosis or treatment. Please consult your physician for health concerns.

+90 850 321 50 00

Pediatric to Adult Hematology Transition Care

Coordinated handover from pediatric to adult hematology

Written by: Saygı Hospital Health Guide Editorial Board
Last updated:

This content has been compiled by the Saygı Hospital Health Guide Editorial Board and is periodically reviewed by a specialist physician.

References (5)

This content is for informational purposes only and does not constitute medical advice. You can book an appointment at our Hematoloji department. Book Appointment →

What is Pediatric to Adult Hematology Transition Care?

Transition of care in pediatric hematology refers to the planned coordinated process of moving adolescents and young adults with chronic hematological disease from pediatric to adult health services. Common conditions include sickle cell disease, hemophilia, thalassemia, congenital cytopenias and survivors of childhood leukemia or lymphoma.

Effective transition begins in early adolescence with disease education, self management training, vocational planning and shared decision making. Joint pediatric and adult clinics, dedicated transition coordinators and written transfer summaries support continuity of care and reduce loss to follow up that historically marks late adolescent years.

Adult providers should expect different psychosocial issues including independent living, fertility, contraception and employment. Long term complications such as iron overload, organ damage and second malignancy risk may need adult subspecialty input. Patient centred timing rather than rigid age cut offs improves engagement.

Symptoms

Process not a disease symptom
Disengagement risk in late teens
Loss to follow up after pediatric service
Hospitalisations rise during transition
Adherence drops without coordination

Risk Factors

Lack of structured transition program
Cognitive impairment from disease
Limited family or social support
Insurance coverage gaps
Geographic distance from adult center

When to See a Doctor?

If you experience any of the following symptoms, seek medical attention promptly:

  • When chronic pediatric hematology disease is present
  • When patient approaches eighteen years
  • When complex therapy needs continuity
  • When self management is being learned

Treatment Methods

01
Begin transition planning in early adolescence
02
Self management training over years
03
Joint pediatric adult transition clinics
04
Written transfer summary and red flags
05
Dedicated transition coordinator role
06
Continued support after transfer for at least year

Which Department to Visit?

You can visit our Hematoloji department for these complaints. Our specialist physicians will create the most suitable treatment plan for you.

Learn About Hematoloji Department

Let us help you

You can make an appointment with our specialists or contact us for your concerns.

Book AppointmentContact Us

Related Health Topics

Other articles from the same department you may want to explore.

Anaemia

Dahiliye (İç Hastalıkları)

Anaemia is a low haemoglobin level that reduces oxygen delivery, causing fatigue, pallor, and shortness of breath. It is not a disease itself but a sign of many underlying conditions. Most cases are correctable with appropriate diagnosis and treatment.

Iron Deficiency Anaemia

Dahiliye (İç Hastalıkları)

Iron deficiency anaemia develops when dietary intake, absorption, or losses create an iron shortfall, most often affecting women and children. Identifying the underlying cause is the core of management, alongside iron replacement.

Vitamin B12 Deficiency

Dahiliye (İç Hastalıkları)

Vitamin B12 deficiency can cause megaloblastic anaemia, neurological symptoms, and cognitive impairment. Early treatment with intramuscular or oral B12 largely prevents irreversible complications.

Hypertension (High Blood Pressure) Management

Dahiliye (İç Hastalıkları)

Hypertension is often called the silent killer because it progresses symptom-free for years and can damage the heart, brain, kidneys, and eyes. Regular monitoring, lifestyle change, and evidence-based drug therapy dramatically reduce cardiovascular risk.

Chronic Kidney Disease

Dahiliye (İç Hastalıkları)

Chronic kidney disease is one of the most common complications of chronic conditions such as diabetes and hypertension, and can be silent in its early stages.

Hepatitis B (HBV)

Dahiliye (İç Hastalıkları)

Hepatitis B is a DNA virus infection causing acute and chronic hepatitis with risk of cirrhosis and hepatocellular carcinoma; diagnosis integrates HBsAg, HBeAg, anti-HBc, and HBV DNA with management based on disease phase using nucleos(t)ide analogues (entecavir, tenofovir) and universal infant vaccination.

Hepatitis C (HCV)

Dahiliye (İç Hastalıkları)

Hepatitis C is an RNA virus causing chronic hepatitis that may progress to cirrhosis and hepatocellular carcinoma; modern direct-acting antiviral (DAA) pangenotypic regimens (sofosbuvir/velpatasvir, glecaprevir/pibrentasvir) achieve sustained virologic response over 95% in 8–12 weeks with universal adult screening and cure for nearly all patients.

Fatty Liver Disease

Dahiliye (İç Hastalıkları)

Non-alcoholic fatty liver disease (NAFLD) is closely related to obesity and metabolic syndrome and is largely reversible with early treatment.

Health Disclaimer: The information on this page is prepared for general informational purposes only. It does not replace medical diagnosis and treatment. Please consult your physician for your complaints. Saygı Hospital does not accept responsibility for actions taken based on the information on this page.